Stem cell therapies are becoming mainstream. From giant pharmaceutical companies like Baxter International , which is conducting a Phase III clinical trial using its CD34+ stem cells derived from a patient's own bone marrow to treat myocardial Ischemia, to small startups like Stemline Therapeutics developing treatments to target cancer stem cells, ... (more)
http://seekingalpha.com/article/1861521-companies-advancing-stem-cell-therapies-could-also-advance-your-portfolio-dollars?source=feed
http://seekingalpha.com/article/1861521-companies-advancing-stem-cell-therapies-could-also-advance-your-portfolio-dollars?source=feed
No comments:
Post a Comment